Patents by Inventor Andrew Murphy

Andrew Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12251440
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: June 29, 2023
    Date of Patent: March 18, 2025
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Publication number: 20250072405
    Abstract: The invention relates generally to genetically modified non-human animals expressing human polypeptides and their methods of use.
    Type: Application
    Filed: September 23, 2024
    Publication date: March 6, 2025
    Inventors: Richard Flavell, Markus Manz, Anthony Rongvaux, Till Strowig, Tim Willinger, Andrew Murphy, Sean Stevens, George Yancopoulos
  • Patent number: 12215148
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: February 4, 2025
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chiayang Lin, Samuel Davis
  • Patent number: 12180272
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: December 31, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chia-Yang Lin, Samuel Davis
  • Publication number: 20240294627
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Application
    Filed: April 19, 2024
    Publication date: September 5, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chia-Yang Lin, Samuel Davis
  • Patent number: 12070632
    Abstract: A method of controlling a blower system of a powered air purifying respirator to deliver a substantially uniform volumetric airflow to a user, the system including a fan powered by a variable speed electric motor, the motor controlled by an electronic control unit for delivering a forced flow of air through at least one filter to a user. There is also provided an air purifying respirator blower system using such a method.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: August 27, 2024
    Assignee: 3M Innovative Properties Company
    Inventors: Sean R. Kilmer, Douglas D. Jensen, Keith K. Mclaughlin, Andrew Murphy
  • Publication number: 20240254208
    Abstract: According to certain embodiments, the present disclosure provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds a target antigen and a second antigen binding domain that binds a complement component. In certain embodiments, the bispecific antigen-binding molecules of the present disclosure are capable of binding to the target antigen with an EC50 of about 10 nM or less, and/or are capable of promoting complement deposition on the target antigen with an EC50 of about 10 nM. In certain embodiments, the bispecific antigen-binding molecules of the disclosure are useful for treating diseases in which inhibition or reduction of the growth of an infectious agent or cancer cell is desired and/or therapeutically beneficial.
    Type: Application
    Filed: February 12, 2020
    Publication date: August 1, 2024
    Inventors: Christos Kyratsous, Chia-Yang Lin, Andrew Murphy, Brinda Prasad, Neil Stahl
  • Patent number: 12017098
    Abstract: There is provided a method of controlling a powered air purifying respirator blower system to deliver a substantially uniform volumetric airflow to a user, the system comprising a fan powered by a battery in communication with a variable speed electric motor, the variable speed electric motor is controlled by an electronic control unit for delivering a forced flow of air through at least one filter to a user, comprising the steps of: (a) determining an estimated system run time by summing a battery run time remaining and a system run time; and (b) altering a speed of the variable speed electric motor when the estimated system run time is equal to or less than a desired system run time.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: June 25, 2024
    Assignee: 3M Innovative Properties Company
    Inventors: Keith K. Mclaughlin, Douglas D. Jensen, Sean R. Kilmer, Andrew Murphy
  • Patent number: 11965020
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Grant
    Filed: May 17, 2023
    Date of Patent: April 23, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chia-Yang Lin, Samuel Davis
  • Publication number: 20240017174
    Abstract: This invention relates to a computer implemented method and a computer program product for providing a virtual robotics programming competition. The method comprising the steps of on a server, providing access for a remote client device to a physics library, a physics engine, a rendering engine and an application programming interface (API) mapping the functions of the physics engine to the rendering engine; setting a programming challenge for a user operating the remote client device; receiving a simulation computer program code for a virtual robot from the remote client device; miming the simulation computer program code in a challenge environment; and grading the performance of the simulation computer program code. The performance of the simulation computer program code can be judged based on the results of a live multiplayer robot battle. In this way, students may compete against each other in robotics competitions without the expense and other pitfalls of having to travel to remote locations.
    Type: Application
    Filed: September 11, 2020
    Publication date: January 18, 2024
    Inventors: Andrew Murphy, Adam Dalton, Evan Darcy
  • Patent number: 11837103
    Abstract: An automatic, autonomous, and aircraft-centric interference advisory method is executed entirely on a fist aircraft operating on a movement area of a runway, the movement are including ramps, taxiways, and runways. The method includes a processor onboard the first aircraft computing a first movement projection for the first aircraft using first aircraft data received at the first aircraft; the processor computing additional second movement projections for multiple second aircraft operating on the movement area of the airport using second data regarding each of the multiple second aircraft; the processor detecting a threat to the first aircraft on approach to a defined intersection of the movement area from any of the multiple second aircraft based on a corresponding second movement projection within a configurable time limit of entry into the defined intersection by the first aircraft; and providing on the first aircraft, a threat advisory for a detected threat.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: December 5, 2023
    Assignee: Architecture Technology Corporation
    Inventors: Eric R. Chartier, Evan Eaves, William Colligan, Andrew Murphy
  • Publication number: 20230362440
    Abstract: This invention relates to a computer implemented method and a computer program product for simulating a 3D object in a browser and sharing that simulation with a plurality of other users on other client devices. There is provided an in-browser simulator comprising: a rendering engine; a physics engine; and an application programming interface (API) mapping the functions of the physics engine to the rendering engine. The API is configured to establish a communication link with the other client devices and to share the simulation data with those devices over the established communication link. In one embodiment, multiple client devices can share their simulations contemporaneously and simulations on one client device can interact with simulations on other devices.
    Type: Application
    Filed: September 21, 2021
    Publication date: November 9, 2023
    Inventors: Andrew Murphy, Adam Dalton, Evan Darcy
  • Publication number: 20230348569
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Application
    Filed: June 29, 2023
    Publication date: November 2, 2023
    Inventors: Robert BABB, Alina BAUM, Gang CHEN, Cindy GERSON, Johanna HANSEN, Tammy HUANG, Christos KYRATSOUS, Wen-Yi LEE, Marine MALBEC, Andrew MURPHY, William OLSON, Neil STAHL, George D. YANCOPOULOS
  • Publication number: 20230340105
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Application
    Filed: May 17, 2023
    Publication date: October 26, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chia-Yang Lin, Samuel Davis
  • Publication number: 20230285778
    Abstract: There is provided a method of controlling a powered air purifying respirator blower system to deliver a substantially uniform volumetric airflow to a user, the system comprising a fan powered by a battery in communication with a variable speed electric motor, the variable speed electric motor is controlled by an electronic control unit for delivering a forced flow of air through at least one filter to a user, comprising the steps of: (a) determining an estimated system run time by summing a battery run time remaining and a system run time; and (b) altering a speed of the variable speed electric motor when the estimated system run time is equal to or less than a desired system run time.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 14, 2023
    Inventors: Keith K. Mclaughlin, Douglas D. Jensen, Sean R. Kilmer, Andrew Murphy
  • Publication number: 20230279153
    Abstract: The present disclosure relates to molecules capable of binding to both CD20 and PD1, as well as pharmaceutical compositions comprising such molecules and methods of use thereof.
    Type: Application
    Filed: November 9, 2022
    Publication date: September 7, 2023
    Inventors: Yang SHEN, Bei WANG, Naga Suhasini AVVARU, Chia-Yang LIN, Andrew MURPHY, Aynur HERMANN, Jee H. KIM
  • Patent number: 11732030
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 22, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 11727818
    Abstract: A method, executed by a processor, includes the processor receiving signals information from a device located on a departing airplane; verifying an identification of the airplane and identifying an expected departure sequence of aircraft surface states; monitoring and identifying additional signals information received from the mobile device, including comparing the additional signals information to known data; logging the additional signals information, and processing the additional signals information, and determining the logged data corresponds to events indicative of an aircraft surface state; sending an aircraft surface state reached message to Local and Center flight management; and executing a statistical routine and providing statistical data from the execution relating to an occurrence of upcoming aircraft surface state event and sending the statistical data with the aircraft surface state message.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: August 15, 2023
    Assignee: Architecture Technology Corporation
    Inventors: William Colligan, Eric R Chartier, Paul Davis, Andrew Murphy, Douglas Sweet
  • Patent number: 11727824
    Abstract: This invention relates to a system for teaching computer programming comprising a robot farm, a plurality of remote computing devices and a server. The robot farm comprises a plurality of pods, each housing a robot and having a video camera to capture live video of the robot in the pod. The computing devices are each associated with a robot and transmit control commands to the robot to cause the robot to carry out an action and in return receive live video footage of the robot. The server communicates with the robots, the video cameras and the plurality of remote computing devices to relay control commands from the computing devices to the robots and live video from the video cameras to the computing devices. The computing devices further comprise a user interface having panes, including a programming pane for receipt of control commands, and a video feed pane for displaying video feed of the robot.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: August 15, 2023
    Assignee: ROBOTIFY LABS LIMITED
    Inventors: Andrew Murphy, Adam Dalton, Evan Darcy
  • Patent number: 11708407
    Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: July 25, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chia-Yang Lin, Samuel Davis